Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Essity AB ( ($SE:ESSITY.B) ) is now available.
Essity reported a mixed start to 2026, with first-quarter net sales down 5.1% to SEK 33.2bn, mainly due to currency effects, while organic sales inched up 0.4% as higher volumes offset lower price and mix. EBITA excluding items affecting comparability slipped 2% but rose 5% in constant currencies, lifting the margin to 13.9%, while profit and earnings per share declined modestly.
The company completed the acquisition of Edgewell’s North American feminine care business in February, adding 1.1% to group net sales and strengthening its position in the regional personal care market. Operating cash flow improved 16% and leverage fell to a net debt to EBITDA ratio of 0.96, and after quarter-end the board authorized a SEK 3bn share buyback program, signaling continued balance-sheet strength and a shareholder-friendly capital allocation stance.
The most recent analyst rating on ($SE:ESSITY.B) stock is a Sell with a SEK215.00 price target. To see the full list of analyst forecasts on Essity AB stock, see the SE:ESSITY.B Stock Forecast page.
More about Essity AB
Essity AB is a global hygiene and health company that produces tissue, personal care and professional hygiene products. The group focuses on branded consumer goods and professional solutions, with a significant presence in Europe and North America and a growing footprint in key international markets.
Average Trading Volume: 1,552,471
Technical Sentiment Signal: Sell
Current Market Cap: SEK169.3B
Learn more about ESSITY.B stock on TipRanks’ Stock Analysis page.